Gilead Sciences (GILD), Arcus Biosciences (RCUS) Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. AMC
10. META

Go back to Gilead Sciences (GILD), Arcus Biosciences (RCUS) Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies
Gilead Sciences (NASDAQ: GILD) Delayed: 150.56 +0.45 (0.30%)
Previous Close $150.11    52 Week High $108.63 
Open $150.11    52 Week Low $71.39 
Day High $152.10    P/E 83.18 
Day Low $148.22    EPS $1.81 
Volume 5,569,384       

(NYSE: RCUS) Delayed: 25.95 +0.71 (2.81%)
Previous Close $25.24    52 Week High $ 
Open $25.54    52 Week Low $ 
Day High $26.03    P/E N/A 
Day Low $25.06    EPS $ 
Volume 1,111,195